Study: Human blood antibody relieves chronic pain condition

02/1/2010 | National Post (Canada)

U.K. scientists found that almost half of 13 patients with complex regional pain syndrome experienced pain relief for an average of five weeks after receiving a low-dose transfusion of intravenous immunoglobulin, a human blood antibody. "The discovery is expected to have a real impact on the treatment of other unexplained chronic pain conditions," the lead researcher said.

View Full Article in:

National Post (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX